Your browser doesn't support javascript.
loading
AKIRIN2 controls the nuclear import of proteasomes in vertebrates.
de Almeida, Melanie; Hinterndorfer, Matthias; Brunner, Hanna; Grishkovskaya, Irina; Singh, Kashish; Schleiffer, Alexander; Jude, Julian; Deswal, Sumit; Kalis, Robert; Vunjak, Milica; Lendl, Thomas; Imre, Richard; Roitinger, Elisabeth; Neumann, Tobias; Kandolf, Susanne; Schutzbier, Michael; Mechtler, Karl; Versteeg, Gijs A; Haselbach, David; Zuber, Johannes.
Afiliação
  • de Almeida M; Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Vienna, Austria.
  • Hinterndorfer M; Vienna BioCenter PhD Program, Doctoral School of the University at Vienna and Medical University of Vienna, Vienna BioCenter (VBC), Vienna, Austria.
  • Brunner H; Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Vienna, Austria.
  • Grishkovskaya I; Vienna BioCenter PhD Program, Doctoral School of the University at Vienna and Medical University of Vienna, Vienna BioCenter (VBC), Vienna, Austria.
  • Singh K; Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Vienna, Austria.
  • Schleiffer A; Vienna BioCenter PhD Program, Doctoral School of the University at Vienna and Medical University of Vienna, Vienna BioCenter (VBC), Vienna, Austria.
  • Jude J; Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Vienna, Austria.
  • Deswal S; Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Vienna, Austria.
  • Kalis R; MRC Laboratory of Molecular Biology, Cambridge, UK.
  • Vunjak M; Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Vienna, Austria.
  • Lendl T; Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Vienna, Austria.
  • Imre R; Twist Bioscience, San Francisco, CA, USA.
  • Roitinger E; Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Vienna, Austria.
  • Neumann T; Genome Engineering, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Kandolf S; Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Vienna, Austria.
  • Schutzbier M; Vienna BioCenter PhD Program, Doctoral School of the University at Vienna and Medical University of Vienna, Vienna BioCenter (VBC), Vienna, Austria.
  • Mechtler K; Vienna BioCenter PhD Program, Doctoral School of the University at Vienna and Medical University of Vienna, Vienna BioCenter (VBC), Vienna, Austria.
  • Versteeg GA; Department of Microbiology, Immunobiology and Genetics, Max Perutz Labs, University of Vienna, Vienna BioCenter (VBC), Vienna, Austria.
  • Haselbach D; Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Vienna, Austria.
  • Zuber J; Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Vienna, Austria.
Nature ; 599(7885): 491-496, 2021 11.
Article em En | MEDLINE | ID: mdl-34711951
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fatores de Transcrição / Proteínas Nucleares / Núcleo Celular / Complexo de Endopeptidases do Proteassoma / Proteínas de Ligação a DNA Tipo de estudo: Prognostic_studies Limite: Female / Humans / Male Idioma: En Revista: Nature Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Áustria
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fatores de Transcrição / Proteínas Nucleares / Núcleo Celular / Complexo de Endopeptidases do Proteassoma / Proteínas de Ligação a DNA Tipo de estudo: Prognostic_studies Limite: Female / Humans / Male Idioma: En Revista: Nature Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Áustria